EZZ Life Science Holdings (ASX:EZZ) Pretax Margin %: 0.23% (As of Dec. 2025) — 98% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EZZ EZZ Life Science Holdings Ltd ASX:EZZ
49 GF Score
Price A$0.48
GF Value A$1.45
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is EZZ Life Science Holdings Pretax Margin %?

EZZ Life Science Holdings ASX:EZZ +3.23% 49 Pretax Margin % is 0.23% as of Dec. 2025, which is 98% below its 10-year median of 13.19. GuruFocus rates ASX:EZZ with a GF Score™ of 49/100 and a GF Value™ of A$1.45 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 943 Biotechnology companies, EZZ Life Science Holdings ranks better than 79.64% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. EZZ Life Science Holdings's Pre-Tax Income for the six months ended in Dec. 2025 was A$0.06 Mil. EZZ Life Science Holdings's Revenue for the six months ended in Dec. 2025 was A$24.82 Mil. Therefore, EZZ Life Science Holdings's pretax margin for the quarter that ended in Dec. 2025 was 0.23%.

The historical rank and industry rank for EZZ Life Science Holdings's Pretax Margin % or its related term are showing as below:

ASX:EZZ' s Pretax Margin % Range Over the Past 10 Years
Min: 9.58   Med: 13.19   Max: 15.83
Current: 9.58


ASX:EZZ's Pretax Margin % is ranked better than
79.64% of 943 companies
in the Biotechnology industry
Industry Median: -90.37 vs ASX:EZZ: 9.58

EZZ Life Science Holdings  (ASX:EZZ) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


EZZ Life Science Holdings Pretax Margin % Related Terms


EZZ Life Science Holdings Pretax Margin % Historical Data

* Premium members only.

The historical data trend for EZZ Life Science Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EZZ Life Science Holdings Pretax Margin % Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Pretax Margin %
Get a 7-Day Free Trial 12.28 11.85 13.19 14.99 15.83

EZZ Life Science Holdings Semi-Annual Data
Jun20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 7.03 18.85 15.71 15.93 0.23

ASX:EZZ vs VRTX, REGN, RVMD: Pretax Margin % Comparison

For the Biotechnology subindustry, EZZ Life Science Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EZZ Life Science Holdings Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's Pretax Margin % falls into.


ASX:EZZ
49GF Score
EZZ Life Science Holdings Ltd ASX:EZZ
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EZZ Life Science Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

EZZ Life Science Holdings's Pretax Margin for the fiscal year that ended in Jun. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=10.586/66.874
=15.83 %

EZZ Life Science Holdings's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.057/24.816
=0.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of 0.23% mean?
EZZ Life Science Holdings (ASX:EZZ) has a Pretax Margin % of 0.23% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on EZZ Life Science Holdings and its competitors. This is 98% below median its historical median of 13.19. Over the past decade, EZZ Life Science Holdings' Pretax Margin % has ranged from 9.58 to 15.83. According to the industry distribution chart, EZZ Life Science Holdings ranks #192 out of 943 companies in the Biotechnology industry, placing it in the top 20.4%.
Is EZZ Life Science Holdings' Pretax Margin % too high?
EZZ Life Science Holdings' current Pretax Margin % of 0.23% is 98% below median its 10-year median of 13.19. Over the past 10 years, this metric has ranged from a low of 9.58 to a high of 15.83. Based on the distribution chart, EZZ Life Science Holdings ranks #192 out of 943 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, EZZ Life Science Holdings has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EZZ Life Science Holdings' Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, EZZ Life Science Holdings ranks #192 out of 943 companies for Pretax Margin %. This places EZZ Life Science Holdings in the top 20% of its industry — outperforming the majority of peers. Historically, EZZ Life Science Holdings' own Pretax Margin % has ranged from 9.58 to 15.83 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on EZZ Life Science Holdings and its competitors. EZZ Life Science Holdings's current Pretax Margin % is 0.23%, which is 98% below median its own 10-year median of 13.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EZZ Life Science Holdings stock overvalued right now?
Based on GuruFocus' analysis, EZZ Life Science Holdings (ASX:EZZ) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.45, compared to a current price of A$0.48 — trading 66.9% below its estimated fair value. The current Pretax Margin % is 0.23%, which is 98% below median its 10-year median of 13.19. EZZ Life Science Holdings' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For EZZ Life Science Holdings (ASX:EZZ), the current Pretax Margin % is 0.23% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EZZ Life Science Holdings (ASX:EZZ) Overvalued in 2026?

Based on GuruFocus' analysis, EZZ Life Science Holdings stock appears to be undervalued. The current stock price of A$0.48 is trading 66.9% below its estimated GF Value™ of A$1.45. GuruFocus considers EZZ Life Science Holdings to be Possible Value Trap.

Key valuation signals for ASX:EZZ:

  • Pretax Margin %: 0.23% (98% below median its 10-year median of 13.19)
  • GF Value™: A$1.45 vs. price of A$0.48 (66.9% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the ASX:EZZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EZZ Life Science Holdings Business Description

Address 55-59 Parramatta Road, Shop 1, Lidcombe, NSW, AUS, 2141
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.
49GF Score

Get the complete analysis for ASX:EZZ

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.48
Price
A$1.45
GF Value